The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Victor A. Gault

The SAAD Centre for Pharmacy and Diabetes

School of Biomedical Sciences

University of Ulster




Name/email consistency: high



  • The SAAD Centre for Pharmacy and Diabetes, School of Biomedical Sciences, University of Ulster, Coleraine, UK. 2010
  • School of Biomedical Sciences, University of Ulster, Cromore Road, Coleraine BT52 1SA, United Kingdom. 2002 - 2008


  1. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Gault, V.A., Porter, W.D., Flatt, P.R., Hölscher, C. Int. J. Obes. (Lond) (2010) [Pubmed]
  2. C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes. Gault, V.A., Kerr, B.D., Irwin, N., Flatt, P.R. Biochem. Pharmacol. (2008) [Pubmed]
  3. Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetes. Gault, V.A., McClean, P.L., Irwin, N., Power, G.J., McCluskey, J.T., Flatt, P.R. Pancreas (2007) [Pubmed]
  4. Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes. Gault, V.A., Hunter, K., Irwin, N., Greer, B., Green, B.D., Harriott, P., O'Harte, F.P., Flatt, P.R. Biol. Chem. (2007) [Pubmed]
  5. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes. Gault, V.A., Irwin, N., Green, B.D., McCluskey, J.T., Greer, B., Bailey, C.J., Harriott, P., O'harte, F.P., Flatt, P.R. Diabetes (2005) [Pubmed]
  6. Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide. Gault, V.A., Flatt, P.R., Harriott, P., Mooney, M.H., Bailey, C.J., O'Harte, F.P. J. Endocrinol. (2003) [Pubmed]
  7. DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2-Asp13)GIP. Gault, V.A., Irwin, N., Harriott, P., Flatt, P.R., O'Harte, F.P. Cell Biol. Int. (2003) [Pubmed]
  8. Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes. Gault, V.A., Flatt, P.R., O'Harte, F.P. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  9. Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?. Gault, V.A., O'Harte, F.P., Flatt, P.R. Neuropeptides (2003) [Pubmed]
  10. Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. Gault, V.A., Parker, J.C., Harriott, P., Flatt, P.R., O'Harte, F.P. J. Endocrinol. (2002) [Pubmed]
  11. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide. Gault, V.A., Harriott, P., Flatt, P.R., O'Harte, F.P. Biosci. Rep. (2002) [Pubmed]
WikiGenes - Universities